News
The change marks a shift in the Food and Drug Administration’s policy on approving COVID-19 vaccines, which the new ...
Agency leaders said there was evidence to justify approval only for older people and those with medical conditions. Many ...
"The FDA will approve vaccines for high-risk persons and, at the same time, demand robust, gold-standard data on persons at ...
In the NEJM article, the FDA notes that covid booster uptake has been low in the US, with less than a quarter of people ...
Kansas Attorney General Kris Kobach sued Pfizer over its marketing of the COVID-19 vaccine. A federal judge sent the case ...
In an editorial article published in the New England Journal of Medicine, Dr. Vinay Prasad, the newly appointed head of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results